Acute and late toxicity and preliminary outcomes report of moderately hypofractionated helical tomotherapy for localized prostate cancer: a mono-institutional analysis
- 22 October 2019
- journal article
- research article
- Published by Springer Nature in La radiologia medica
- Vol. 125 (2) , 220-227
Abstract
To assess toxicity and clinical outcomes of moderately hypofractionated helical tomotherapy (HT) for the curative treatment of localized prostate cancer (PC).Keywords
This publication has 29 references indexed in Scilit:
- Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based GuidelineJournal of Urology, 2019
- Moderate hypofractionation for prostate cancerTranslational Andrology and Urology, 2018
- Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trialAdvances in Radiation Oncology, 2017
- Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate CancerJournal of Clinical Oncology, 2016
- A Comparison of Long-Term Treatment-Related Toxicities Between Moderately Hypofractionated and Conventionally Fractionated Radiation Therapy for Localized Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trialThe Lancet Oncology, 2014
- Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate CancerJournal of Clinical Oncology, 2013
- Prostate alpha/beta revisited – an analysis of clinical results from 14 168 patientsActa Oncologica, 2012
- Hypofractionated Intensity-Modulated Radiotherapy (70 Gy at 2.5 Gy Per Fraction) for Localized Prostate Cancer: Cleveland Clinic ExperienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the ProstateJAMA, 2005